Nerva Review (2026): A Clinician’s Honest Take on the Mindset Health IBS App
What the Peters 2023 adherence data actually shows, who the app works for, and when clinician-led gut-directed hypnotherapy is the faster route. No referral relationship with Mindset Health or any digital therapeutics vendor.
Nerva is a real gut-directed hypnotherapy product from a serious company. But the manufacturer’s own data shows 91% of paying users never finished the program. That single fact changes how the rest of the marketing should be read.
This is an unaffiliated clinical review. No referral arrangement, no affiliate links, no consulting relationship with Mindset Health. The goal is a fair reading of what Nerva does, where its evidence base actually lives, and which IBS presentations it fits — and which ones it does not.
Before you weigh Nerva — do you respond to hypnosis?
60-second self-assessment based on the Stanford & Tellegen scales.
Hypnotizability Assessment
Adapted from the Stanford & Tellegen clinical scales
When reading a book or watching a movie, do you get so absorbed you lose track of time?
Short answer
Nerva is a well-designed self-directed gut-directed hypnotherapy app that works for a specific user profile: mildly-to-moderately symptomatic, easily hypnotisable, and self-motivated enough to complete 42 daily sessions. The manufacturer’s own data (Peters 2023, PMID 36661117) shows only 9% of paying users completed the program, with outcome data available for just 6.7% of starters. For refractory IBS, comorbid anxiety, or anyone whose previous self-help attempts have failed, clinician-led gut-directed hypnotherapy (76% response rate in Miller 2015, PMID 25736234) is the more reliable first move.
What You'll Learn
- What Nerva actually is (and is not)
- How to read the Peters 2023 numbers
- How the app stacks up to Miller 2015 and Hasan 2019
- The specific user profile where Nerva fits
- Four cases where clinician work is the faster route
- Sticker price vs real cost-per-response
What Nerva Actually Is
Nerva is a smartphone application developed by Mindset Health, a Melbourne-based digital therapeutics company that also produces Evia (menopause symptom management) and Mindset (substance use). The product is specifically built for irritable bowel syndrome and delivers a 6-week self-directed protocol modelled on clinician-delivered gut-directed hypnotherapy. Mindset Health markets Nerva as an evidence-based tool for symptom improvement, positioning it as an alternative to medication, low-FODMAP restriction, or traditional therapy.
The core of the app is a library of 42 pre-recorded audio hypnosis sessions, each roughly 15 minutes long, intended to be listened to daily. Interspersed with the audio sessions are short educational modules covering IBS physiology, gut-brain axis concepts, and stress-response mechanics, along with a library of breathing and relaxation exercises. The current subscription price is approximately $67 USD per year, after a 7-day free trial. Users commit to a roughly 6-week listening schedule (one session per day, with a handful of rest days), after which the protocol repeats on a maintenance cycle.
The underlying hypnotic framework draws on the Manchester Protocol, which is the clinician-delivered 7–12 session programme originally developed and validated at the University Hospital of South Manchester under Peter Whorwell. Mindset Health has been transparent that Nerva is an adaptation of this framework rather than a different methodology. Where the clinician format uses live induction, individualised metaphor, and session-by-session adjustment, the app format uses scripted audio with no real-time adaptation.
That distinction matters for the rest of this review. Nerva is a real gut-directed hypnotherapy product, but the delivery mechanism is fundamentally different from what generated the strong clinical evidence base that Mindset Health’s marketing points to.
What Peters 2023 Really Shows
The single most-cited piece of evidence for Nerva is a 2023 paper published in Neurogastroenterology & Motility: Peters SL, Gibson PR, Halmos EP. “Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: A retrospective evaluation.” 2023 Apr;35(4):e14533. PMID 36661117. DOI 10.1111/nmo.14533.
This paper is worth understanding in detail because almost every secondary source that quotes Nerva effectiveness numbers derives them from it. Critically, the authors disclose direct financial relationships with Mindset Health — one author is a paid consultant and shareholder in the company. That disclosure does not automatically invalidate the findings, but it is essential context.
Of 2,843 trial starters, 1,428 paid (50%), 253 completed all 42 sessions (9%), and only 190 had end-of-program outcome data (6.7%). The other 93% are unknown. This is the manufacturer’s own retrospective.
Source: Peters SL, Gibson PR, Halmos EP. Neurogastroenterol Motil. 2023 (PMID 36661117)
The “64% symptom improvement” figure that sometimes appears in Nerva marketing is technically correct but needs the denominator made explicit. It is 64% of the 6.7% of starters for whom outcome data was captured. It is not 64% of people who buy the app and it is not 64% of people who try the app.
The authors themselves are explicit about the problem. Their own conclusion reads: “Adherence to app-delivered gut-directed hypnotherapy was low. A controlled trial comparing face-to-face to app-delivered GDH is indicated.” That is a remarkable sentence for a manufacturer-affiliated study to include. It effectively says: we cannot claim equivalence to clinician-delivered gut-directed hypnotherapy on the basis of this data. That caveat is often missing in derivative content.
A second study, Simicich/Muniz/Scheffrahn/Elkins 2024 (full text in PMC11179457), offers a directionally similar picture from independent authors. It reports that 31.7% of paid users persisted to end-of-program surveys and completed an average of 18.22 of 42 audio sessions (about 43%). That is higher than Peters 2023’s 9% full-completion figure, but still a long way from the level of exposure the Manchester Protocol was validated on.
The honest takeaway is not that Nerva does not work for anyone. For the subset of users who finish the protocol, the majority do report improvement, which is consistent with what the Manchester Protocol has always shown. The takeaway is that finishing the protocol without a clinician is much harder than the marketing suggests, and the clinical evidence for the app format is not yet equivalent to the evidence for the clinician format.
Nerva vs Clinician-Led GDH: What the Numbers Actually Say
The comparison that matters most is not Nerva versus placebo — it is Nerva versus clinician-delivered gut-directed hypnotherapy, the format that generated the underlying evidence base Nerva leans on. Here are the numbers side by side.
| Study | Format | Response / outcome | Sample |
|---|---|---|---|
| Miller 2015 (PMID 25736234) | Clinician-delivered (in-person, Manchester Protocol) | 76% response rate; benefits persist 5+ years | n = 1,000 consecutive audit patients |
| Hasan 2019 (PMID 30702396) | Clinician-delivered, face-to-face vs live telehealth | 76% (in-person) vs 65% (telehealth) — not statistically different | Randomised comparison |
| Peters 2023 (PMID 36661117) | Self-directed app (Nerva) | 64% improvement among completers with outcome data — but only 6.7% of starters had outcome data, 9% completed the program | 2,843 trial starters / 190 measured completers (author-affiliated) |
| Simicich 2024 (PMC11179457) | Self-directed app (Nerva), independent analysis | 31.7% of paid users reached end-of-program survey; avg 18.22 of 42 sessions completed (43%) | Independent evaluation |
Two things jump out of the table. First, Hasan 2019 effectively establishes that live clinician presence is the load-bearing element of gut-directed hypnotherapy, not physical in-room attendance. Telehealth with a clinician gets close to in-person numbers. Second, the step from “live clinician via video” to “pre-recorded audio with no clinician” is where the adherence problem appears. That is the gap Nerva is trying to cross, and the Peters 2023 data is the first systematic attempt to measure how well the crossing holds up.
Unsure whether you’re a Nerva-profile or a clinician-profile case?
A free 15-minute fit consultation sorts it out honestly — including telling you if the app is the right starting point.
Apply for a Free Fit Consultation →Who Nerva Works Well For
Nerva is not a bad product — it is a targeted product. There is a specific user profile where the app does the job it is designed to do, and being honest about that profile is more useful than a blanket endorsement or dismissal.
Nerva is a reasonable first step if you:
- ✓Score medium-to-high on hypnotisability. Roughly 70% of the population is moderately-to-highly hypnotisable and will respond to recorded hypnotic induction. If you find guided meditations, Yoga Nidra, or audio-based relaxation practices already work for you, you are likely in this group.
- ✓Have mild-to-moderate IBS symptoms — symptoms are disruptive but not severe, you are not on multiple medications for GI issues, and you have not cycled through years of unsuccessful treatment attempts.
- ✓Are genuinely self-directed with health habits. You already maintain a consistent daily practice (exercise, meditation, journaling, sleep hygiene) without external accountability. People who successfully build new daily habits alone are the people who complete 42-session protocols alone.
- ✓Have no significant comorbid anxiety, depression, or trauma history that would interact with a non-adaptive, non-supervised hypnotic protocol.
- ✓Are cost-sensitive and want a low-risk screening tool to confirm that gut-directed hypnotherapy works for you before committing to clinician sessions.
Is moderately-to-highly hypnotisable on standardised scales. For this group, a well-produced audio induction can genuinely work — which is why the 9% of Nerva users who finish the program track the Manchester Protocol response curve so closely.
Source: Stanford Hypnotic Susceptibility Scale population norms
In that profile, Nerva delivers what it promises. $67 USD for a structured 42-session protocol is a reasonable gamble, and if you are one of the 9% who finish, the outcomes line up with what the Manchester Protocol has always produced. The problem is that IBS patients presenting for help are often not in that profile — they are presenting because self-directed approaches have not been enough.
Who Should Skip Nerva and Start With a Clinician
There are four presentations where starting with an app is statistically likely to waste time, and where the clinician format is the faster route to resolution. These are not hypothetical categories — they are the profiles that most commonly arrive at a clinician’s office after a self-directed attempt did not move the needle.
1. Refractory IBS
You have tried low-FODMAP (properly, with a dietitian), one or more IBS-specific medications (rifaximin, linaclotide, eluxadoline, or antispasmodics), probiotics, and/or fibre supplementation without durable relief. Refractory presentations are where gut-directed hypnotherapy earns its strongest evidence (Miller 2015 was specifically a refractory audit population), but the refractory profile is also the least likely to complete a self-directed protocol alone. A clinician can identify why previous approaches failed and adapt the hypnotic protocol to that specific pattern.
2. Comorbid anxiety, panic, or trauma
IBS rarely arrives alone. Roughly 40–60% of clinical IBS populations meet criteria for comorbid anxiety. Some patients also carry a trauma history that interacts with deep relaxation in unpredictable ways. Pre-recorded audio cannot adjust the pacing, notice an abreaction, or switch the induction if relaxation triggers hypervigilance. A live clinician can. For the anxious-gut profile, starting with an app often produces frustration or a flat response that gets misread as “hypnotherapy does not work for me” — when in fact it was the delivery format that did not fit.
3. Failed prior self-directed attempts
If you have already tried Nerva, Calm, Headspace, the IBS Audio Programme, or another self-directed hypnotherapy or meditation app and not gotten results, the Peters 2023 adherence data is not going to look different the second time. The self-directed delivery is the variable that did not work. Repeating the same format and hoping for a different outcome is a common pattern; switching to a clinician-led format is the evidence-based next move.
4. Complex gut-brain presentations
IBS plus pelvic floor dysfunction, visceral hypersensitivity, severe bloating, food-related anxiety, post-infectious IBS, or post-cholecystectomy symptom patterns all benefit from individualised protocols rather than a generic 42-session audio library. The Manchester Protocol itself is not a single script — it is a framework that a trained clinician adapts session by session. An app by definition cannot do that.
Cost-Per-Response: The Sticker Price vs the Real Price
The argument for Nerva that carries the most weight with cost-sensitive users is simple: $67 USD per year is dramatically less than a clinician’s fee. At face value that is true. A 3-session clinician commitment in Calgary runs roughly $660 CAD. Nerva is about one-tenth of that on paper.
But sticker price is not cost-per-response, and cost-per-response is the number that actually matters when you are weighing treatments. If a $67 product has a 9% completion rate and outcome data on 6.7% of starters, the effective cost per confirmed symptom response is meaningfully higher than $67 — and the time cost of not improving for another 6 weeks is separate from the dollar cost entirely.
Thinking about it as “dollars per responder”
This is a back-of-envelope calculation, not a clinical trial finding — but the directional logic holds. Take the Peters 2023 denominators:
- • 1,428 people paid $67 USD each. Total: ~$95,676 USD spent.
- • 190 of those people had measured outcome data. 64% of those (122 people) reported significant improvement.
- • Effective dollars-per-confirmed-responder: $95,676 / 122 ≈ $784 USD.
That is in the same ballpark as a 3-session clinician commitment, except the clinician commitment comes with a 76% response rate in the underlying Manchester audit data rather than a 6.7%-of-starters outcome-data rate.
The honest way to frame this: if you are in the profile where the app works — self-directed, hypnotisable, mild-to-moderate, no comorbidities — the $67 is an efficient spend and the math above does not really apply to you individually. You are paying $67 for a product that will likely work for you. If you are outside that profile, paying $67 for a product with a 91% non-completion rate is not the saving it appears to be, because the most likely outcome is that you end up paying $67 plus the clinician fee anyway, six weeks later, with less motivation than when you started.
Curious what the clinician-led track looks like?
See session structure, pricing, and insurance coverage before you decide.
See How We Work →What Nerva Genuinely Does Well
It is worth giving the product full credit where it earns it, because an honest review is not a takedown. A few things Nerva does better than most of the gut-brain-axis category.
- Protocol fidelity. The audio content is derived from legitimate gut-directed hypnotherapy frameworks, not generic relaxation content re-badged for IBS. That matters. Many “IBS hypnosis” apps on the store are effectively generic meditations with the word “gut” inserted into the script. Nerva is not.
- Production quality. The recordings are professionally produced with experienced hypnotherapy voice work. Poor audio quality is one of the top silent reasons self-directed hypnosis attempts fail; Nerva does not have that problem.
- Transparent manufacturer data. Despite the financial conflict of interest, Mindset Health did publish the Peters 2023 numbers. A lot of digital therapeutics companies would have quietly not published a paper with a 9% completion rate. The field is better for having the data.
- Screening utility. For a hypnotisable user, completing the first 7–10 days of Nerva is a cheap way to find out if gut-directed hypnotherapy works on your nervous system. If day 10 is showing some response, that is a strong predictor a clinician course would work too. If day 10 is silent, that is useful information before committing to clinician fees.
- Complementary to clinician work. Used alongside clinician sessions, the Nerva audio library is a reasonable daily home-practice asset — especially during the “between-sessions” windows where consistent exposure is what drives the gut-brain axis retraining effect. Many clinicians are comfortable with clients running both in parallel.
Among the 190 Nerva users with measured end-of-program outcome data, 64% reported significant symptom improvement. That is consistent with what the clinician-delivered Manchester Protocol has always shown — but it is the finishers the number describes, not the starters.
Source: Peters SL, Gibson PR, Halmos EP (2023), PMID 36661117
Is Nerva Right For You? A Decision Tree
The cleanest way to think about this is to walk through four yes/no questions before you download the app. If you land on “Nerva first”, buy it. If you land on “clinician first”, the $67 is not the savings it looks like.
Disclosure & Independence
Readers deserve to know who is writing a clinical review and what the commercial relationships look like. Here is the full picture for this page.
- No affiliation with Mindset Health. Calgary Gut Hypnotherapy has no referral, revenue-share, affiliate-link, or consulting arrangement with Mindset Health, Nerva, Evia, or any other Mindset Health product. No compensation is received from promoting or not promoting the app.
- No digital therapeutics vendor relationships. The same applies to all other IBS-focused DTx products — Regulora, Mahana IBS, Zemedy, Cara Care, and the various prescription-model clinician networks. This page is written from a clinical practice perspective, not a technology partnership perspective.
- Commercial incentive, disclosed. Calgary Gut Hypnotherapy is a fee-for-service clinical practice. The author has a financial interest in clients choosing clinician-led sessions, including sessions at this practice. That is the reason this page bends over backward to describe the specific user profile for whom Nerva is the correct starting point — an honest clinical review should acknowledge where the product is a good fit even if that means the reviewer earns less.
- Hypnotherapy is complementary care. It is not a substitute for medical diagnosis or treatment. Hypnotherapy is not a regulated health profession in Alberta. A gastroenterologist referral remains the appropriate first step for new or worsening GI symptoms to rule out structural disease.
- Scope of practice. This practice follows the Manchester Protocol as a reference framework. Work is limited to the gut-brain-axis retraining that protocol was designed for. Response rates cited on this page (76%, 64%, etc.) come from published research — they are not claimed as the author’s own outcomes.
- No fabricated testimonials on this page. Any client examples referenced in related content use pseudonyms with explicit disclosure. Names are changed to protect client confidentiality.
The Bottom Line
Nerva is a legitimate, well-built, self-directed gut-directed hypnotherapy app from a company that has meaningfully invested in getting the protocol right. For a specific user profile — hypnotisable, mildly symptomatic, self-directed, no major comorbidities — it is a reasonable first move and a good screening tool.
The honest caveats are adherence and the evidence base for the app format specifically. The manufacturer’s own data (Peters 2023, PMID 36661117) shows a 9% completion rate and outcome data on 6.7% of starters. An independent look (Simicich 2024, PMC11179457) shows 43% average session completion. Neither of those adherence profiles is what the Manchester Protocol’s 76% response evidence was built on — that evidence came from a clinician-delivered format where adherence problems are managed in real time.
If you are the right profile, buy the app. If you are refractory, anxious, traumatised, complex, or already tried a self-directed attempt that did not work, a clinician is the faster and ultimately cheaper route. Either way, the underlying modality — gut-directed hypnotherapy itself — is one of the most evidence-backed treatments available for IBS, and choosing any format that gets you to the protocol is better than continuing to cycle through medication and dietary restriction alone.
Frequently Asked Questions
What is Nerva and how does it work?+
Nerva is a smartphone app built by Mindset Health that delivers a 6-week self-directed gut-directed hypnotherapy program for irritable bowel syndrome. The core protocol is 42 pre-recorded audio sessions (roughly 15 minutes each), layered with short educational modules and a breathing exercise library. It is modelled on the clinician-delivered Manchester Protocol but removes the live therapist from the equation. Users listen daily on their own schedule. Current pricing is approximately $67 USD per year for the full program. There is a 7-day free trial before payment kicks in.
Is Nerva FDA-approved or clinically validated?+
Nerva is not an FDA-approved medical device. It is marketed as a health and wellness app, which is a different regulatory category with a much lower evidence bar. The strongest clinical data on Nerva specifically is the Peters 2023 retrospective (PMID 36661117), which was authored by researchers with direct financial ties to Mindset Health. There is no randomised controlled trial comparing Nerva to a clinician-delivered gut-directed hypnotherapy arm, or to a credible placebo. The underlying protocol (gut-directed hypnotherapy delivered by a trained clinician) has strong evidence, but that evidence does not automatically transfer to a self-directed app.
What does Peters 2023 actually say about Nerva’s effectiveness?+
Peters, Gibson, and Halmos (2023, PMID 36661117) looked at 2,843 users who started a free trial. Of those, 1,428 (50%) purchased the app, and only 253 (9%) completed all 42 sessions. Outcome data was available for just 190 completers, which is 6.7% of starters. Among those 190 completers, 64% reported significant symptom improvement. The authors. Who disclose being paid consultants and shareholders in Mindset Health. Themselves concluded that "adherence to app-delivered gut-directed hypnotherapy was low" and that "a controlled trial comparing face-to-face to app-delivered GDH is indicated." That sentence tells you how to read the headline 64% figure honestly.
How does Nerva compare to seeing a clinician for IBS hypnotherapy?+
Miller 2015 (PMID 25736234, n=1,000) reports a 76% response rate for clinician-delivered gut-directed hypnotherapy on the Manchester Protocol, with benefits persisting 5+ years. Hasan 2019 (PMID 30702396) found face-to-face GDH produced 76% response versus 65% for live telehealth GDH. A non-significant difference, suggesting live clinician presence (not physical location) is what matters. Nerva removes the clinician entirely. The app is cheaper per purchase, but the Peters 2023 completion and outcome-data rates mean the effective cost-per-response is less favourable than the sticker price implies. For self-motivated users with mild symptoms, the gap may not matter. For refractory or complex cases, it matters a lot.
Who is Nerva best for?+
Nerva is a reasonable first step for people who are easily hypnotisable, have mild-to-moderate IBS symptoms, are comfortable with structured daily self-practice, and have no significant comorbid anxiety, trauma, or treatment-resistant history. Cost-sensitive users who want to test whether gut-directed hypnotherapy is a fit before investing in clinician sessions can use the 6-week protocol as a low-risk screening tool. If symptoms meaningfully improve by week 3 or 4, the app may be all that is needed. If nothing moves by week 4, that is useful clinical information too. It signals that clinician-led work or a different modality is likely the better next step.
When should I skip Nerva and go straight to a clinician?+
Skip the app and start with a clinician if you have severe or refractory IBS that has not responded to low-FODMAP, medications, or prior self-help attempts; if you have comorbid anxiety, panic, PTSD, or significant trauma history that complicates relaxation-based protocols; if a previous self-directed hypnosis or meditation app did not work; or if your gut-brain presentation is complex (IBS plus pelvic floor dysfunction, severe bloating, or significant food-related anxiety). Self-directed audio cannot adapt to resistance, plateau, or abreaction the way a live clinician can. In those cases the self-directed route is more likely to fail, which costs time and can entrench a belief that "hypnotherapy does not work for me" when in fact the delivery format was the wrong fit.
Is Nerva covered by insurance in Canada?+
Nerva is generally not covered by Canadian provincial health insurance or by most employer-sponsored extended health benefit plans, because it is classified as a wellness app rather than a regulated health service delivered by a practitioner. Clinician-delivered hypnotherapy in Canada is also generally not directly covered under extended health benefit plans. Some clients can claim related programs (stress management, behavioural change) under a Wellness Spending Account (WSA) if their plan offers one. Coverage rules depend entirely on plan design, so check with your insurance provider before booking. Clinician-led sessions do generate detailed receipts you can submit for any reimbursement your provider may approve.
Can I use Nerva and see a hypnotherapist at the same time?+
Yes. Many clients use the Nerva daily audio library as home practice between clinician sessions, which leverages the strength of each format: the clinician tailors the protocol and works on plateaus, resistance, or trauma material, and the app provides consistent daily reinforcement in between. This hybrid pattern is common and generally encouraged. The important caveat is to let the clinician know you are using the app so any audio content can be reviewed for consistency with the in-session work. Mixing fundamentally different hypnotic frameworks without coordination can occasionally blunt progress.
Not sure which side of the line you’re on?
- 15 minutes, no obligation
- Honest read on whether Nerva fits your profile
- Or whether clinician-led GDH is the faster route
- Virtual across Canada or in-person in Calgary
📅 Currently accepting new IBS clients this month
About the Author
Danny M.
Registered Clinical Hypnotherapist specializing in gut-directed hypnotherapy for IBS, functional digestive disorders, and gut-related anxiety. Follows the Manchester Protocol as a reference framework and works with clients across Calgary and Canada via virtual sessions.
Learn more about our approach